Unknown

Dataset Information

0

3D Telomere Structure Analysis to DetectGenomic Instability and Cytogenetic Evolutionin Myelodysplastic Syndromes.


ABSTRACT: The disease course of myelodysplastic syndromes (MDS) features chromosome instability and clonal evolution, leading to the sequential acquisition of novel cytogenetic aberrations and the accumulation of these abnormalities in the bone marrow. Although clonal cytogenetic abnormalities can be detected by conventional cytogenetics in 50% of patients with MDS, such distinguishing patterns are lacking in the other 50%. Despite the increase in the prognostic value of some biomarkers, none of them is specific and able to discriminate between stable and unstable patients that subsequently progress to acute myeloid leukemia. This pilot study aimed to investigate the potential use of the 3D telomere profiling to detect genomic instability in MDS patients with or without clonal cytogenetic evolution. The comparison between different time points in patients with cytogenetic changes showed that in the CD34+ MDS cells, there was a significant decrease in the total number of telomeric signals, the average intensity of signals and the total intensity of telomeres. By contrast, the number of aggregates increased during cytogenetic evolution (p < 0.001). This pattern was observed only for MDS patients with cytogenetic evolution but was absent in patients without cytogenetic changes. In conclusion, we demonstrated that the 3D nuclear telomere organization was significantly altered during the MDS disease course, and may have contributed to cytogenetic clonal evolution.

SUBMITTER: Rangel-Pozzo A 

PROVIDER: S-EPMC6526472 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

3D Telomere Structure Analysis to DetectGenomic Instability and Cytogenetic Evolutionin Myelodysplastic Syndromes.

Rangel-Pozzo Aline A   Corrêa de Souza Daiane D   Schmid-Braz Ana Teresa AT   de Azambuja Ana Paula AP   Ferraz-Aguiar Thais T   Borgonovo Tamara T   Mai Sabine S  

Cells 20190402 4


The disease course of myelodysplastic syndromes (MDS) features chromosome instability and clonal evolution, leading to the sequential acquisition of novel cytogenetic aberrations and the accumulation of these abnormalities in the bone marrow. Although clonal cytogenetic abnormalities can be detected by conventional cytogenetics in 50% of patients with MDS, such distinguishing patterns are lacking in the other 50%. Despite the increase in the prognostic value of some biomarkers, none of them is s  ...[more]

Similar Datasets

| S-EPMC2413090 | biostudies-other
| S-EPMC4350661 | biostudies-literature
| S-EPMC3823121 | biostudies-literature
| S-EPMC4466575 | biostudies-other
| S-EPMC5841340 | biostudies-literature
| S-EPMC5021885 | biostudies-literature
| S-EPMC4340482 | biostudies-literature
| S-EPMC8439599 | biostudies-literature
| S-EPMC5439522 | biostudies-literature
2019-10-30 | PXD013609 | Pride